Jeremy M. Levin is SVP Strat Transactions at BRISTOL MYERS SQUIBB CO (BMY). They have made 5 open-market trades across 1 company since 2017, most recently 2026-03-23.
CIK 0001256153
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $670K since 2017, never a sale. Across 5 scored buys the stock is up 10.5% at ninety days, and 5.7 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 80% | 60% |
| Avg Move | +3.4% | +7.3% | +10.5% |
| Alpha | +4.4% | +7.8% | +5.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OVID | BUY | 2024-03-18 | 2024-03-20 | $2.76 | $101K | +2.0% | +8.0% | -73.6% |
| OVID | BUY | 2020-08-28 | 2020-09-01 | $5.84 | $50K | +13.8% | +10.4% | +24.8% |
| OVID | BUY | 2019-10-08 | 2019-10-10 | $2.50 | $150K | +1.4% | +16.4% | +83.2% |
| OVID | BUY | 2019-02-22 | 2019-02-26 | $2.00 | $150K | -5.4% | -12.2% | -21.5% |
| OVID | BUY | 2017-08-25 | 2017-08-28 | $7.15 | $219K | +5.4% | +13.7% | +39.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.